Clinical Trial

Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer

Name: Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer — clinical trial record (NCT07021911)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: COMBaRT

Recruiting

View on ClinicalTrials.gov →

Summary

The primary objective of the study is to describe the tolerance profile of radiation treatments performed during systemic treatment with new drugs (molecular targeted therapies, immunotherapy, others).

Trial Details

NCT Number	NCT07021911
Lead Sponsor	Fondazione Policlinico Universitario Campus Bio-Medico
Conditions	Breast Cancer, Radiotherapy; Complications
Enrollment	300 participants
Start Date	2023-05-17
Primary Completion	2029-05-17 (estimated)
Study Completion	2029-05-17 (estimated)
Updated on ClinicalTrials.gov	2025-06-15